BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35787068)

  • 1. Assessing performance validity during attention-deficit/hyperactivity disorder evaluations: Cross-validation of non-memory embedded validity indicators.
    Ausloos-Lozano JE; Bing-Canar H; Khan H; Singh PG; Wisinger AM; Rauch AA; Ogram Buckley CM; Petry LG; Jennette KJ; Soble JR; Resch ZJ
    Dev Neuropsychol; 2022 Aug; 47(5):247-257. PubMed ID: 35787068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-validation of non-memory-based embedded performance validity tests for detecting invalid performance among patients with and without neurocognitive impairment.
    White DJ; Korinek D; Bernstein MT; Ovsiew GP; Resch ZJ; Soble JR
    J Clin Exp Neuropsychol; 2020 Jul; 42(5):459-472. PubMed ID: 32397824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-validation of the Trail Making Test as a non-memory-based embedded performance validity test among veterans with and without cognitive impairment.
    Peak AM; Marceaux JC; Chicota-Carroll C; Soble JR
    J Clin Exp Neuropsychol; 2024 Feb; 46(1):16-24. PubMed ID: 38007610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance and symptom validity assessment in attention deficit/hyperactivity disorder: Base rates of invalidity, concordance, and relative impact on cognitive performance.
    Ovsiew GP; Cerny BM; Boer AB; Petry LG; Resch ZJ; Durkin NM; Soble JR
    Clin Neuropsychol; 2023 Oct; 37(7):1498-1515. PubMed ID: 36594201
    [No Abstract]   [Full Text] [Related]  

  • 5. Multivariable analysis of the relative utility and additive value of eight embedded performance validity tests for classifying invalid neuropsychological test performance.
    Jennette KJ; Rhoads T; Resch ZJ; Cerny BM; Leib SI; Sharp DW; Ovsiew GP; Soble JR
    J Clin Exp Neuropsychol; 2022 Sep; 44(7):451-460. PubMed ID: 36197342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of embedded validity indicators from the Stroop Color and Word Test among adults referred for clinical evaluation of suspected or confirmed attention-deficit/hyperactivity disorder.
    Khan H; Rauch AA; Obolsky MA; Skymba H; Barwegen KC; Wisinger AM; Ovsiew GP; Jennette KJ; Soble JR; Resch ZJ
    Psychol Assess; 2022 Jul; 34(7):697-703. PubMed ID: 35357873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of the Rey 15-Item Test, recognition trial, and error scores for detecting noncredible neuropsychological performance in a mixed clinical sample of veterans.
    Bailey KC; Soble JR; O'Rourke JJF
    Clin Neuropsychol; 2018 Jan; 32(1):119-131. PubMed ID: 28555516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-validating the Dot Counting Test Among an Adult ADHD Clinical Sample and Analyzing the Effect of ADHD Subtype and Comorbid Psychopathology.
    Abramson DA; White DJ; Rhoads T; Carter DA; Hansen ND; Resch ZJ; Jennette KJ; Ovsiew GP; Soble JR
    Assessment; 2023 Mar; 30(2):264-273. PubMed ID: 34643101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivariate examination of embedded indicators of performance validity for ADHD evaluations: A targeted approach.
    Finley JA; Brooks JM; Nili AN; Oh A; VanLandingham HB; Ovsiew GP; Ulrich DM; Resch ZJ; Soble JR
    Appl Neuropsychol Adult; 2023 Sep; ():1-14. PubMed ID: 37703401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the Psychometric Properties of Eight Embedded Performance Validity Tests in the Rey Auditory Verbal Learning Test, Wechsler Memory Scale Logical Memory, and Brief Visuospatial Memory Test-Revised Recognition Trials for Detecting Invalid Neuropsychological Test Performance.
    Pliskin JI; DeDios Stern S; Resch ZJ; Saladino KF; Ovsiew GP; Carter DA; Soble JR
    Assessment; 2021 Dec; 28(8):1871-1881. PubMed ID: 32484371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining Conners Continuous Performance Test-3 (CPT-3) Embedded Performance Validity Indicators in an Adult Clinical Sample Referred for ADHD Evaluation.
    Scimeca LM; Holbrook L; Rhoads T; Cerny BM; Jennette KJ; Resch ZJ; Obolsky MA; Ovsiew GP; Soble JR
    Dev Neuropsychol; 2021 Aug; 46(5):347-359. PubMed ID: 34256665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Not so fast! Limitations of processing speed and working memory indices as embedded performance validity tests in a mixed neuropsychiatric sample.
    Ovsiew GP; Resch ZJ; Nayar K; Williams CP; Soble JR
    J Clin Exp Neuropsychol; 2020 Jul; 42(5):473-484. PubMed ID: 32498648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-validating the Clinical Assessment of Attention Deficit-Adult symptom validity scales for assessment of attention deficit/hyperactivity disorder in adults.
    Finley JA; Cerny BM; Brooks JM; Obolsky MA; Haneda A; Ovsiew GP; Ulrich DM; Resch ZJ; Soble JR
    J Clin Exp Neuropsychol; 2024 Mar; 46(2):111-123. PubMed ID: 37994688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of executive function in children with attention deficit/hyperactivity disorder comorbid with high functioning autism].
    Zhang SH; Wang P; Yang BR; Zhong YY; Wang YF
    Zhonghua Yi Xue Za Zhi; 2020 Aug; 100(31):2446-2451. PubMed ID: 32819061
    [No Abstract]   [Full Text] [Related]  

  • 15. Further Validation of the Conner's Adult Attention Deficit/Hyperactivity Rating Scale Infrequency Index (CII) for Detection of Non-Credible Report of Attention Deficit/Hyperactivity Disorder Symptoms.
    Cook CM; Bolinger E; Suhr J
    Arch Clin Neuropsychol; 2016 Jun; 31(4):358-64. PubMed ID: 27193367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric implications of failure on one performance validity test: a cross-validation study to inform criterion group definition.
    Rhoads T; Neale AC; Resch ZJ; Cohen CD; Keezer RD; Cerny BM; Jennette KJ; Ovsiew GP; Soble JR
    J Clin Exp Neuropsychol; 2021 Jul; 43(5):437-448. PubMed ID: 34233580
    [No Abstract]   [Full Text] [Related]  

  • 17. The Divergent Roles of Symptom and Performance Validity in the Assessment of ADHD.
    White DJ; Ovsiew GP; Rhoads T; Resch ZJ; Lee M; Oh AJ; Soble JR
    J Atten Disord; 2022 Jan; 26(1):101-108. PubMed ID: 33084457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Base Rates of Performance and Symptom Validity Test Failures in Active Duty and Veteran Samples Referred for Attention-Deficit/Hyperactivity Disorder Evaluation.
    Shura RD; Armistead-Jehle P
    Arch Clin Neuropsychol; 2024 May; 39(4):523-527. PubMed ID: 38073319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Out of sight, out of mind: The impact of material-specific memory impairment on Rey 15-Item Test performance.
    Soble JR; Rhoads T; Carter DA; Bernstein MT; Ovsiew GP; Resch ZJ
    Psychol Assess; 2020 Nov; 32(11):1087-1093. PubMed ID: 32853003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of race and other demographic factors on the false positive rates of five embedded Performance Validity Tests (PVTs) in a Veteran sample.
    Denning JH; Horner MD
    J Clin Exp Neuropsychol; 2024 Feb; 46(1):25-35. PubMed ID: 38353039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.